Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: van bever l. Radiother Oncol. 2021 Oct;163:242-243. doi: 10.1016/j.radonc.2021.07.002. Epub 2021 Jul 16. Radiother Oncol. 2021. PMID: 34274395 No abstract available.
Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: van bever l. Radiother Oncol. 2021 May;158:268-275. doi: 10.1016/j.radonc.2021.03.002. Epub 2021 Mar 10. Radiother Oncol. 2021. PMID: 33711412 Free article. Clinical Trial.
Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: van bever l. Radiother Oncol. 2021 Aug;161:255-256. doi: 10.1016/j.radonc.2021.06.009. Epub 2021 Jun 10. Radiother Oncol. 2021. PMID: 34119590 No abstract available.
Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).
Robijns J, Lodewijckx J, Puts S, Vanmechelen S, Van Bever L, Claes S, Pannekoeke L, Timmermans A, Noé L, Govers M, Van de Werf E, Maes A, Bulens P, Mebis J. Robijns J, et al. Among authors: van bever l. Lasers Surg Med. 2022 Mar;54(3):374-383. doi: 10.1002/lsm.23475. Epub 2021 Sep 4. Lasers Surg Med. 2022. PMID: 34481420 Clinical Trial.
Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by He et al.
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: van bever l. Radiother Oncol. 2022 Apr;169:143-144. doi: 10.1016/j.radonc.2022.01.002. Epub 2022 Jan 19. Radiother Oncol. 2022. PMID: 35065145 No abstract available.
A long-term follow-up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis.
Robijns J, Lodewijckx J, Claes M, Lenaerts M, Van Bever L, Claes S, Pannekoeke L, Verboven K, Noé L, Maes A, Bulens P, Mebis J. Robijns J, et al. Among authors: van bever l. Lasers Surg Med. 2022 Dec;54(10):1261-1268. doi: 10.1002/lsm.23608. Epub 2022 Oct 2. Lasers Surg Med. 2022. PMID: 36183377
A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J, Van Bever L, Hermans S, Claes M, Lodewijckx J, Lenaerts M, Tuts L, Vandaele E, Vinken E, Noé L, Verboven K, Maes A, Van de Velde AS, Bulens P, Bulens P, Van den Bergh L, Mebis J. Robijns J, et al. Among authors: van bever l. Support Care Cancer. 2023 Oct 11;31(12):625. doi: 10.1007/s00520-023-08096-5. Support Care Cancer. 2023. PMID: 37819539 Clinical Trial.
13 results